Written by Klarity Editorial Team
Published: Jun 20, 2026

If you’re a psychiatrist or psychiatric nurse practitioner thinking about treating anxiety patients through telehealth, you’re probably wondering: Can I actually prescribe controlled anxiety meds remotely? What are the rules in my state? And what’s the financial upside?
Good news: as of 2026, federal telehealth flexibilities allow you to prescribe benzodiazepines and other controlled substances for anxiety entirely via video visits — no in-person exam required. But state rules vary dramatically on who can prescribe what, especially for PMHNPs. Here’s the real talk on telehealth anxiety prescribing, state licensing quirks, reimbursement economics, and how platforms like Klarity remove the patient acquisition headache.
Let’s start with the big one: can you prescribe Xanax, Klonopin, or other Schedule IV anxiolytics via telehealth without ever seeing the patient in person?
Yes — through at least December 2026. The DEA and HHS extended COVID-era telemedicine flexibilities that waive the Ryan Haight Act’s in-person exam requirement for controlled substances. That means you can:
Over 7 million controlled substance prescriptions for ADHD, anxiety, and other conditions were written via telemedicine in 2024 alone under these rules. The extension through 2026 gives the DEA time to finalize permanent telehealth prescribing regulations (expected late 2026), which may introduce new safeguards like special telemedicine registrations but will likely preserve remote prescribing in some form.
What this means for you: If you’re licensed in a state and have a DEA registration there, you can treat anxiety patients via telehealth and e-prescribe controlled meds just like you would in-person. No temporary COVID workaround — this is the standard of care right now.
The catch: Stay alert. When the DEA publishes permanent rules, you may need to comply with new requirements (periodic in-person visits, additional patient ID verification, or registration updates). But for the next 12+ months, the path is clear.
Federal law sets the floor, but state laws determine who can prescribe what — and this is where psychiatrists and PMHNPs have very different realities.
If you’re a board-certified psychiatrist, you have unrestricted prescribing authority in any state where you hold a license. You can prescribe:
State telehealth quirks for psychiatrists:
Bottom line for MDs: You can treat anxiety via telehealth in any state you’re licensed. Just stay compliant with PDMP checks and evolving federal rules.
For psychiatric nurse practitioners, the answer to ‘can I prescribe anxiety meds via telehealth?’ is: it depends where you’re licensed.
Your prescribing authority is governed by whether your state grants:
State-by-state breakdown for PMHNPs:
New York (Full Practice): As of 2022, New York grants full independence. No written practice agreement or physician collaboration required. You can prescribe SSRIs, benzos, and other anxiety meds on your own. Same telehealth rules as psychiatrists.
California (Transitioning to Independence): Historically restricted, but AB 890 created a pathway. As of 2023, experienced NPs can become 103 NPs (practice without physician protocols in group settings). In 2026, they can apply for 104 NP status — full solo independent practice. Until you achieve 104 status, you need physician standardized procedures. Once certified, you can prescribe anxiety meds via telehealth independently.
Texas (Restricted): You must have a Prescriptive Authority Agreement with a Texas physician. You can prescribe benzodiazepines (Schedule IV) if your collaborating physician authorizes it. But you cannot prescribe Schedule II stimulants outside hospital settings — a key limitation if you’re treating comorbid ADHD. Your supervising physician must review charts periodically. Telehealth is allowed, but your collaboration must be in place.
Florida (Reduced, with exceptions): You need a written protocol with a supervising physician. Florida limits NPs to 7-day supplies of Schedule II controlled substances unless you’re a psychiatric NP treating a mental health disorder — then you can prescribe more. You can prescribe benzodiazepines for anxiety under your protocol. Florida offers an out-of-state telehealth provider registration, but if you only hold that (not a full FL license), you cannot prescribe controlled substances remotely in Florida.
Pennsylvania (Restricted): Collaborative agreement required throughout your career. The physician must review a percentage of your charts (100% for Schedule II prescriptions within 24 hours). You can prescribe anxiety meds including benzos if your agreement permits, but physician involvement is mandatory.
Illinois (Reduced → Full Practice with experience): New PMHNPs need a collaborative agreement. After 4,000 clinical hours and 250 CE hours, you can apply for Full Practice Authority. Even with FPA, you need a one-time physician sign-off to prescribe benzodiazepines — essentially a physician attesting that you’re authorized to prescribe Schedule IV anxiolytics. After that, you’re independent.
What this means for PMHNPs:
Let’s talk money. Treating anxiety via telehealth is clinically effective, but is it financially viable?
Medicare reimbursement (2026 rates):
These are solid rates for mental health. Medicare recognizes the value of psychiatric care and pays relatively well compared to primary care for similar time spent. And here’s the kicker: telehealth visits are paid at the same rate as in-person through at least 2025 (likely extended into 2026), thanks to temporary telehealth parity measures.
Private insurance: Generally pays 100-150% of Medicare rates, depending on the plan. A 15-minute med check might net you $100-$120 from a commercial payer. States like California, Illinois, and New York have telehealth parity laws requiring private insurers to reimburse virtual visits at in-person rates — no penalty for seeing patients remotely.
Medicaid: Lower rates (roughly 50-60% of Medicare), but high patient volume can offset this. A Medicaid 90792 might pay ~$85; a 99213 around $40-50. Many states expanded Medicaid telehealth coverage permanently post-COVID, so these patients are accessible remotely.
NP reimbursement difference: If you’re a PMHNP billing under your own NPI, Medicare reimburses at 85% of the physician fee schedule. So that $95 med check becomes ~$81 for an NP. Some private payers also discount NP rates slightly. ‘Incident to’ billing (where the NP’s service is billed under a supervising physician’s NPI at 100%) is rarely feasible in psychiatry because each visit is a direct provider-patient interaction, not an auxiliary service.
What this means for your practice:
The overhead for telehealth is minimal — no office rent, reduced malpractice costs in some states, and platforms often handle billing/credentialing. That’s why many psychiatrists and PMHNPs are shifting toward telehealth or hybrid models.
Here’s what no one tells you about starting a telepsychiatry practice: acquiring patients is expensive and time-consuming.
DIY marketing reality check:
When you factor in agency/consultant fees, staff time to handle and qualify leads, no-shows from unvetted prospects, and months of investment before results, the true cost per acquired patient is often $200-500+ — and that’s if you know what you’re doing.
The Klarity model: Instead of gambling on marketing channels, you pay a standard listing fee per new patient lead who books with you. No upfront marketing spend. No monthly subscription. No wasted ad budget on clicks that don’t convert.
What you get:
Frame it this way: Would you rather spend $4,000/month on Google Ads, SEO consultants, and directory listings with no guarantee of ROI, or pay a predictable fee per booked patient and let the platform handle acquisition?
For most providers — especially those starting out, scaling, or entering a new market — the platform model removes all the risk. You get guaranteed patient flow and only pay when you’re earning.
Telehealth opens the door to treating patients in multiple states — critical when you’re looking at states like Texas (psychiatrist-to-population ratio of 1:8,966) or Florida (1:8,577) with massive provider shortages.
The rule: You must hold an active license in the state where the patient is located at the time of the telehealth visit. It doesn’t matter where you’re sitting — if your patient is in Florida, you need a Florida license to treat them remotely.
Interstate licensing options:
Practical tip: If you want to maximize patient access via telehealth, get licensed in 2-3 high-demand states. Platforms like Klarity often help with credentialing and can match you with patients in states where you’re licensed.
Anxiety disorders are the most common mental health condition in the U.S. — affecting ~40 million adults. Post-pandemic, demand has surged. And unlike complex psychiatric conditions requiring intensive in-person care, anxiety medication management is:
Provider shortages create opportunity: In Texas, one psychiatrist serves nearly 9,000 residents. In Florida, it’s 1:8,577. These states desperately need more anxiety prescribers. Telehealth lets you reach underserved areas without relocating.
Can psychiatrists prescribe benzodiazepines via telehealth in 2026?
Yes. Federal rules allow psychiatrists to prescribe Schedule IV anxiolytics (Xanax, Klonopin, Ativan) via telehealth without an in-person exam through at least December 2026. You must comply with state PDMP requirements.
Can PMHNPs prescribe anxiety meds independently?
It depends on the state. In Full Practice Authority states (New York, eventually California), yes. In restricted states (Texas, Pennsylvania, Florida), you need a collaborative agreement with a physician.
Do I need to see anxiety patients in person first before prescribing remotely?
Not under current federal rules (extended through 2026). You can conduct the entire treatment — initial eval, diagnosis, and prescribing — via telehealth. Some states may have additional requirements, but none currently mandate in-person visits for anxiety treatment.
What’s the difference between a psychiatrist and PMHNP for anxiety prescribing?
Psychiatrists (MD/DO) have full independent prescribing authority in all states. PMHNPs’ authority varies by state — some can prescribe independently, others need physician oversight. Both can effectively manage anxiety medications.
How much does Medicare pay for anxiety medication management?
An initial evaluation (90792) pays ~$202. A 15-minute follow-up (99213) pays ~$95. A 25-minute visit (99214) pays ~$136. These rates are the same for telehealth as in-person through 2026.
Can I prescribe controlled substances for anxiety in Florida via telehealth?
Yes, if you’re fully licensed in Florida. Florida law permits telehealth prescribing of Schedule II controlled substances for psychiatric disorders. Benzodiazepines (Schedule IV) have no special telehealth restrictions. You must check the Florida PDMP before prescribing.
Do I need a DEA license in every state I practice via telehealth?
Yes. You need a separate DEA registration for each state where you prescribe controlled substances, even if you’re treating patients remotely.
What happens when the DEA finalizes permanent telehealth rules in late 2026?
The DEA is expected to allow continued telehealth prescribing of controlled substances, possibly with new requirements like a special telemedicine registration or periodic in-person visits. The goal is to preserve access while preventing abuse. Stay tuned for final rules.
Can I treat anxiety patients in multiple states via telehealth?
Yes, if you hold active licenses in those states. Consider using the Interstate Medical Licensure Compact (IMLC) if you’re a psychiatrist to expedite multi-state licensing.
How does Klarity Health help with patient acquisition for anxiety treatment?
Klarity matches you with pre-qualified anxiety patients seeking treatment. You pay per booked appointment (not per click or monthly subscription), eliminating upfront marketing costs and risk. The platform handles credentialing, telehealth infrastructure, and patient matching.
If you’re a psychiatrist, you can treat anxiety patients via telehealth in any state you’re licensed, prescribe controlled medications remotely, and get paid the same as in-person visits. The path is clear.
If you’re a PMHNP, your authority depends on your state’s practice laws — but in FPA states (and increasingly in others), you have the same prescribing power as a psychiatrist for anxiety treatment.
The economics are solid: Medicare pays $95-$200 per visit, private insurance often more, and telehealth overhead is minimal. The catch? Patient acquisition. DIY marketing costs $200-500+ per patient when you factor in all the hidden costs — agency fees, wasted ad spend, staff time, and months of investment before results.
That’s where platforms like Klarity make sense: pay only when a qualified patient books with you, skip the marketing risk entirely, and focus on what you do best — treating anxiety.
Ready to expand your practice without the patient acquisition headache? Explore joining Klarity’s provider network and start seeing anxiety patients on your schedule, in states where you’re licensed, with zero upfront marketing spend.
Find the right provider for your needs — select your state to find expert care near you.